Walleye Capital LLC Gilead Sciences, Inc. Call Options Transaction History

Walleye Capital LLC

$46.2 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $332,950 - $419,950	-5,000 Reduced 7.1%	65,400 $5.48 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $3.14 Million - $3.63 Million	-49,800 Reduced 41.43%	70,400 $4.83 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $8.93 Million - $10.9 Million	-124,700 Reduced 50.92%	120,200 $8.8 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $5.98 Million - $6.78 Million	81,600 Added 49.97%	244,900 $19.8 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $5.08 Million - $5.54 Million	68,700 Added 72.62%	163,300 $12.2 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $2.66 Million - $3.03 Million	35,000 Added 58.72%	94,600 $7.29 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $2.54 Million - $2.9 Million	32,900 Added 123.22%	59,600 $4.95 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $548,416 - $787,336	8,800 Added 49.16%	26,700 $2.29 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $1.07 Million - $1.22 Million	17,900 New	17,900 $1.1 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $759,570 - $882,000	-10,500 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $2.56 Million - $3.28 Million	-40,900 Reduced 79.57%	10,500 $785,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $6.18 Million - $6.8 Million	-100,300 Reduced 66.12%	51,400 $3.34 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $8.05 Million - $8.88 Million	128,700 Added 559.57%	151,700 $9.62 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $853,806 - $957,443	-13,800 Reduced 37.5%	23,000 $1.55 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $2.3 Million - $2.58 Million	36,800 New	36,800 $2.39 Million

Others Institutions Holding GILD

# of Institutions

1,942

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.12 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.75 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.6 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account